These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 24991785)

  • 1. Early use of thiopurines or methotrexate reduces major abdominal and perianal surgery in Crohn's disease.
    Kariyawasam VC; Selinger CP; Katelaris PH; Jones DB; McDonald C; Barr G; Chapman G; Colliwshaw J; Lunney PC; Middleton K; Wang RR; Huang T; Andrews J; Leong RW
    Inflamm Bowel Dis; 2014 Aug; 20(8):1382-90. PubMed ID: 24991785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thiopurines prevented surgical recurrence in patients with Crohn's disease after intestinal resection: Strategy based on risk stratification.
    Guo J; Chen BL; Chen ZH; Luo XP; Qiu Y; Zhang SH; Feng R; He Y; Zeng ZR; Song XM; Ben-Horin S; Mao R; Chen MH
    J Gastroenterol Hepatol; 2018 Mar; 33(3):608-614. PubMed ID: 28804920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Timing of Thiopurine or Anti-TNF Initiation Is Associated with the Risk of Major Abdominal Surgery in Crohn's Disease: A Retrospective Cohort Study.
    González-Lama Y; Suárez C; González-Partida I; Calvo M; Matallana V; de la Revilla J; Magaz M; Bernardo C; Agudo B; Ibarrola P; Relea L; Arévalo J; Vera MI; Abreu L
    J Crohns Colitis; 2016 Jan; 10(1):55-60. PubMed ID: 26520164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic features of Crohn's disease associated with failure of medical treatment.
    Moran GW; Dubeau MF; Kaplan GG; Yang H; Seow CH; Fedorak RN; Dieleman LA; Barkema HW; Ghosh S; Panaccione R;
    Clin Gastroenterol Hepatol; 2014 Mar; 12(3):434-42.e1. PubMed ID: 23978351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thiopurines are associated with a reduction in surgical re-resections in patients with Crohn's disease: a long-term follow-up study in a regional and academic cohort.
    van Loo ES; Vosseberg NW; van der Heide F; Pierie JP; van der Linde K; Ploeg RJ; Dijkstra G; Nieuwenhuijs VB
    Inflamm Bowel Dis; 2013 Dec; 19(13):2801-8. PubMed ID: 24189041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased effectiveness of early therapy with anti-tumor necrosis factor-α vs an immunomodulator in children with Crohn's disease.
    Walters TD; Kim MO; Denson LA; Griffiths AM; Dubinsky M; Markowitz J; Baldassano R; Crandall W; Rosh J; Pfefferkorn M; Otley A; Heyman MB; LeLeiko N; Baker S; Guthery SL; Evans J; Ziring D; Kellermayer R; Stephens M; Mack D; Oliva-Hemker M; Patel AS; Kirschner B; Moulton D; Cohen S; Kim S; Liu C; Essers J; Kugathasan S; Hyams JS;
    Gastroenterology; 2014 Feb; 146(2):383-91. PubMed ID: 24162032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mercaptopurine versus placebo to prevent recurrence of Crohn's disease after surgical resection (TOPPIC): a multicentre, double-blind, randomised controlled trial.
    Mowat C; Arnott I; Cahill A; Smith M; Ahmad T; Subramanian S; Travis S; Morris J; Hamlin J; Dhar A; Nwokolo C; Edwards C; Creed T; Bloom S; Yousif M; Thomas L; Campbell S; Lewis SJ; Sebastian S; Sen S; Lal S; Hawkey C; Murray C; Cummings F; Goh J; Lindsay JO; Arebi N; Potts L; McKinley AJ; Thomson JM; Todd JA; Collie M; Dunlop MG; Mowat A; Gaya DR; Winter J; Naismith GD; Ennis H; Keerie C; Lewis S; Prescott RJ; Kennedy NA; Satsangi J;
    Lancet Gastroenterol Hepatol; 2016 Dec; 1(4):273-282. PubMed ID: 28404197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive factors of response of perianal Crohn's disease to azathioprine or 6-mercaptopurine.
    Lecomte T; Contou JF; Beaugerie L; Carbonnel F; Cattan S; Gendre JP; Cosnes J
    Dis Colon Rectum; 2003 Nov; 46(11):1469-75. PubMed ID: 14605564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term prognosis of crohn's disease and its temporal change between 1981 and 2012: a hospital-based cohort study from Korea.
    Park SH; Yang SK; Park SK; Kim JW; Yang DH; Jung KW; Kim KJ; Ye BD; Byeon JS; Myung SJ; Yoon YS; Yu CS; Kim JH
    Inflamm Bowel Dis; 2014 Mar; 20(3):488-94. PubMed ID: 24412992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Major Abdominal and Perianal Surgery in Crohn's Disease: Long-term Follow-up of Australian Patients With Crohn's Disease.
    Toh JWT; Wang N; Young CJ; Rickard MJFX; Keshava A; Stewart P; Kariyawasam V; Leong R;
    Dis Colon Rectum; 2018 Jan; 61(1):67-76. PubMed ID: 29215479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of timing and duration of thiopurine treatment on first perianal surgery in Crohn's disease: UK population-based study (1995-2009).
    Chhaya V; Saxena S; Cecil E; Subramanian V; Curcin V; Majeed A; Pollok RC
    Inflamm Bowel Dis; 2015 Feb; 21(2):385-91. PubMed ID: 25569740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative Use of Methotrexate and the Risk of Early Postoperative Complications in Patients with Inflammatory Bowel Disease.
    Afzali A; Park CJ; Zhu K; Hu JK; Sharma P; Sinanan MN; Lee SD
    Inflamm Bowel Dis; 2016 Aug; 22(8):1887-95. PubMed ID: 27057681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Has there been a change in the natural history of Crohn's disease? Surgical rates and medical management in a population-based inception cohort from Western Hungary between 1977-2009.
    Lakatos PL; Golovics PA; David G; Pandur T; Erdelyi Z; Horvath A; Mester G; Balogh M; Szipocs I; Molnar C; Komaromi E; Veres G; Lovasz BD; Szathmari M; Kiss LS; Lakatos L
    Am J Gastroenterol; 2012 Apr; 107(4):579-88. PubMed ID: 22233693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged azathioprine treatment reduces the need for surgery in early Crohn's disease.
    Qiu Y; Chen BL; Feng R; Zhang SH; He Y; Zeng ZR; Ben-Horin S; Peyrin-Biroulet L; Mao R; Chen MH
    J Gastroenterol Hepatol; 2018 Mar; 33(3):664-670. PubMed ID: 28940780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of timing and duration of thiopurine treatment on first intestinal resection in Crohn's disease: national UK population-based study 1989-2010.
    Chatu S; Saxena S; Subramanian V; Curcin V; Yadegarfar G; Gunn L; Majeed A; Pollok RC
    Am J Gastroenterol; 2014 Mar; 109(3):409-16. PubMed ID: 24469612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of immunomodulator use as early therapy in pediatric Crohn's disease.
    Jacobstein DA; Mamula P; Markowitz JE; Leonard M; Baldassano RN
    J Clin Gastroenterol; 2006 Feb; 40(2):145-8. PubMed ID: 16394876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thiopurine effectiveness in patients with Crohn's disease: a study of genetic and clinical predictive factors.
    Koifman E; Karban A; Mazor Y; Chermesh I; Waterman M; Almog R; Ben-Horin S; Eliakim R; Krivoy N; Efrati E; Chowers Y
    Inflamm Bowel Dis; 2013 Jul; 19(8):1639-44. PubMed ID: 23669401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methotrexate for Refractory Crohn's Disease Compared with Thiopurines: A Retrospective Non-head-to-head Controlled Study.
    Huang Z; Chao K; Li M; Zhi M; Tang J; Hu P; Gao X
    Inflamm Bowel Dis; 2017 Mar; 23(3):440-447. PubMed ID: 28129286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic role of methotrexate in pediatric Crohn's disease.
    Djurić Z; Šaranac L; Budić I; Pavlović V; Djordjević J
    Bosn J Basic Med Sci; 2018 Aug; 18(3):211-216. PubMed ID: 29338679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of thiopurines on the risk of surgical recurrence in patients with Crohn's disease after first intestinal surgery.
    Papay P; Reinisch W; Ho E; Gratzer C; Lissner D; Herkner H; Riss S; Dejaco C; Miehsler W; Vogelsang H; Novacek G
    Am J Gastroenterol; 2010 May; 105(5):1158-64. PubMed ID: 20010925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.